Pen13Arg
General Information
DCTPep ID DCTPep02543
Peptide Name Pen13Arg
Sequence RIWFQNRRMRWRR
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Cell-penetrating peptides
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
HeLa WT | Human papillomavirus-related endocervical adenocarcinoma | 50% Cytotoxicity=36 ± 5.7 μM | MTS/PMS assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: HD50>128 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02543
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C87H137N35O16S1
Absent amino acids ACDEGHKLPSTVY
Theoretical pI 12.70
Acidic residues 0
Basic residues 6
Polar residues 1
Molecular weight (Average) 1961.33
Molecular weight (Monoisotopic) 1960.07
Common amino acids R
Net charge 6
Instability index (II) 135.62
Aliphatic index 30.00
Grand average of hydropathicity (GRAVY) -2.046
Half Life
1 hours (mammalian reticulocytes, in vitro).
2 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 11000
Abs 0.1% (=1 g/l) 5.608
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23085001
Title Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure
Doi 10.1016/j.bbamem.2012.10.010
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_8801